Literature DB >> 16128666

Discontinuing cardiovascular medications at the end of life: lipid-lowering agents.

Annette M Vollrath1, Christian Sinclair, James Hallenbeck.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16128666     DOI: 10.1089/jpm.2005.8.876

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


× No keyword cloud information.
  20 in total

1.  Statin discontinuation in nursing home residents with advanced dementia.

Authors:  Jennifer Tjia; Sarah L Cutrona; Daniel Peterson; George Reed; Susan E Andrade; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2014-11-04       Impact factor: 5.562

2.  A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group.

Authors:  Amy P Abernethy; Noreen M Aziz; Ethan Basch; Janet Bull; Charles S Cleeland; David C Currow; Diane Fairclough; Laura Hanson; Joshua Hauser; Danielle Ko; Linda Lloyd; R Sean Morrison; Shirley Otis-Green; Steve Pantilat; Russell K Portenoy; Christine Ritchie; Graeme Rocker; Jane L Wheeler; S Yousuf Zafar; Jean S Kutner
Journal:  J Palliat Med       Date:  2010-11-24       Impact factor: 2.947

3.  Developing the evidence base for palliative care: formation of the Palliative Care Research Cooperative and its first trial.

Authors:  Thomas W LeBlanc; Jean S Kutner; Danielle Ko; Jane L Wheeler; Janet Bull; Amy P Abernethy
Journal:  Hosp Pract (1995)       Date:  2010

4.  Statin use in cancer patients with brain metastases: a missed communication opportunity at the end of life.

Authors:  Jacqueline A Mullvain; Kevin R Kozak; John S Moody; Toby C Campbell
Journal:  Support Care Cancer       Date:  2015-02-07       Impact factor: 3.603

Review 5.  Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

Authors:  Carole Parsons; Carmel M Hughes; A Peter Passmore; Kate L Lapane
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

6.  Strategies to support recruitment of patients with life-limiting illness for research: the Palliative Care Research Cooperative Group.

Authors:  Laura C Hanson; Janet Bull; Kathryn Wessell; Lisa Massie; Rachael E Bennett; Jean S Kutner; Noreen M Aziz; Amy Abernethy
Journal:  J Pain Symptom Manage       Date:  2014-05-23       Impact factor: 3.612

7.  Evaluation of Prescribing Medications for Terminal Cancer Patients near Death: Essential or Futile.

Authors:  Hye Ran Lee; Seong Yoon Yi; Do Yeun Kim
Journal:  Cancer Res Treat       Date:  2013-09-30       Impact factor: 4.679

8.  Use of unnecessary medications by patients with advanced cancer: cross-sectional survey.

Authors:  Angelo Fede; Michele Miranda; Daniella Antonangelo; Ligia Trevizan; Henrique Schaffhausser; Bruno Hamermesz; Camile Zimmermann; Auro Del Giglio; Rachel P Riechelmann
Journal:  Support Care Cancer       Date:  2010-07-21       Impact factor: 3.603

Review 9.  Rationalizing prescribing for older patients with multimorbidity: considering time to benefit.

Authors:  Holly M Holmes; Lillian C Min; Michael Yee; Ravi Varadhan; Jenny Basran; William Dale; Cynthia M Boyd
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

Review 10.  Secondary stroke prevention strategies for the oldest patients: possibilities and challenges.

Authors:  Cheryl D Bushnell; Cathleen S Colón-Emeric
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.